Cite
HARVARD Citation
Fujita, R. et al. (2020). A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers. Cancer biology & therapy. 21 (6), pp. 549-559. [Online].